233 related articles for article (PubMed ID: 10440436)
21. A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections.
Matthews P; Alpert M; Rahav G; Rill D; Zito E; Gardiner D; Pedersen R; Babinchak T; McGovern PC;
BMC Infect Dis; 2012 Nov; 12():297. PubMed ID: 23145952
[TBL] [Abstract][Full Text] [Related]
22. Sulbactam/ampicillin versus cefotetan in the treatment of obstetric and gynecologic infections.
Scalambrino S; Mangioni C; Milani R; Regallo M; Norchi S; Negri L; Carrera S; Vigano EF; Ruffilli MP; Canale MP
Suppl Int J Gynecol Obstet; 1989; 2():21-7. PubMed ID: 2679680
[TBL] [Abstract][Full Text] [Related]
23. Treatment of childhood complicated community-acquired pneumonia with amoxicillin/sulbactam.
Lovera D; Arbo A
J Chemother; 2005 Jun; 17(3):283-8. PubMed ID: 16038522
[TBL] [Abstract][Full Text] [Related]
24. An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers.
Harkless L; Boghossian J; Pollak R; Caputo W; Dana A; Gray S; Wu D
Surg Infect (Larchmt); 2005; 6(1):27-40. PubMed ID: 15865549
[TBL] [Abstract][Full Text] [Related]
25. [The use of ampicillin/sulbactam (Unasyn) in treating inflammatory urological diseases].
Perepanova TS; Kotliarova GA; Kondrat'eva EM; Siniukhin VN; Derevianko II; Safin RN
Antibiot Khimioter; 1991 Jun; 36(6):21-5. PubMed ID: 1898184
[TBL] [Abstract][Full Text] [Related]
26. Worldwide clinical experience with sultamicillin.
Pitts NE; Gilbert GS; Knirsch AK; Noguchi Y
APMIS Suppl; 1989; 5():23-34. PubMed ID: 2660868
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of a beta-lactamase inhibitor combination for serious intraabdominal infections.
Walker AP; Nichols RL; Wilson RF; Bivens BA; Trunkey DD; Edmiston CE; Smith JW; Condon RE
Ann Surg; 1993 Feb; 217(2):115-21. PubMed ID: 8439209
[TBL] [Abstract][Full Text] [Related]
28. Sulbactam/ampicillin for treatment of polymicrobial pelvic infections.
Hemsell DL
Drugs; 1986; 31 Suppl 2():22-5. PubMed ID: 3013569
[TBL] [Abstract][Full Text] [Related]
29. Clinical results of a multicenter study with sulbactam/ampicillin for the treatment of patients with lower respiratory and urinary tract infections.
De Simone C; Chiodo F; Delia S; Pastore G; Scalise G; Sorice F; Tonietti G; Zanussi C; Paoloni M; Gargiulo M
J Chemother; 1991 Oct; 3(5):321-7. PubMed ID: 1809811
[TBL] [Abstract][Full Text] [Related]
30. Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial.
Li JT; Lu Y; Hou J; Chen YF; Miao JZ; Jia YX; Hou J; Zhang XZ; Chen DK; Hu WZ; Li LJ; Liu DM; Wang Z; Wu J; Gu JM; Wang HL; Zhang YL; Sun L
Clin Infect Dis; 1997 Mar; 24(3):498-505. PubMed ID: 9114206
[TBL] [Abstract][Full Text] [Related]
31. [Unasyn in severe hospital infections].
Sechser T; Hatala M; Svácek J; Modr Z
Cas Lek Cesk; 1991 May; 130(14):438-44. PubMed ID: 2070390
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and cost of ampicillin-sulbactam and ticarcillin-clavulanate in the treatment of hospitalized patients with bacterial infections.
McKinnon PS; Neuhauser MM
Pharmacotherapy; 1999 Jun; 19(6):724-33. PubMed ID: 10391418
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii.
Corbella X; Ariza J; Ardanuy C; Vuelta M; Tubau F; Sora M; Pujol M; Gudiol F
J Antimicrob Chemother; 1998 Dec; 42(6):793-802. PubMed ID: 10052904
[TBL] [Abstract][Full Text] [Related]
34. Clinical evaluation of sulbactam plus ampicillin in the treatment of general pediatric infections.
Bassetti D; Solbiati M; Ravelli A; Martini A; Viola S; Burgio RG
APMIS Suppl; 1989; 5():41-4. PubMed ID: 2660870
[TBL] [Abstract][Full Text] [Related]
35. Role of sultamicillin and ampicillin/sulbactam in the treatment of upper and lower bacterial respiratory tract infections.
Lode H
Int J Antimicrob Agents; 2001 Sep; 18(3):199-209. PubMed ID: 11673031
[TBL] [Abstract][Full Text] [Related]
36. [Pharmacokinetic, bacteriological and clinical studies of sulbactam/ampicillin in pediatric patients].
Motohiro T; Sakata Y; Oda K; Aramaki M; Tanaka K; Koga T; Shimada Y; Fujimoto T; Yamashita F; Sakamoto H
Jpn J Antibiot; 1989 Mar; 42(3):773-90. PubMed ID: 2664252
[TBL] [Abstract][Full Text] [Related]
37. [Sulbactam/ampicillin in comparison with cefuroxime for infections of the lower respiratory tract. Results of a prospective, randomized comparative study].
Schwigon CD; Cuhorst R; Gabor M; Zinndorf J; Springsklee M
Med Klin (Munich); 1993 Jan; 88(1):16-20. PubMed ID: 8437527
[TBL] [Abstract][Full Text] [Related]
38. Clinical evaluation of sulbactam/ampicillin in Japan.
Shimada K
Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):171S-174S. PubMed ID: 2686916
[TBL] [Abstract][Full Text] [Related]
39. Randomized comparative study of ampicillin/sulbactam vs. ceftriaxone for treatment of soft tissue and skeletal infections in children.
Kulhanjian J; Dunphy MG; Hamstra S; Levernier K; Rankin M; Petru A; Azimi P
Pediatr Infect Dis J; 1989 Sep; 8(9):605-10. PubMed ID: 2677956
[TBL] [Abstract][Full Text] [Related]
40. Successful treatment of skin and soft tissue infection due to carbapenem-resistant Acinetobacter baumannii by ampicillin-sulbactam and meropenem combination therapy.
Hiraki Y; Yoshida M; Masuda Y; Inoue D; Tsuji Y; Kamimura H; Karube Y; Takaki K; Kawano F
Int J Infect Dis; 2013 Dec; 17(12):e1234-6. PubMed ID: 23791858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
